Table 2.

Summary of immunoreactivities

Diagnosis	Percentage of positive cells	No. of cases
Proliferative endometrium without evidence of hyperplasia or neoplasia (13 cases)	>75% to 100%*	13 (100%)
	≤75%, >25%	0 (0%)
	≤25%, >5%	0 (0%)
	≤5%	0 (0%)
Endometrial hyperplasia with or without atypia (8 cases)	>75% to 100%	1 (12.5%)
	-≤75%, >25%	4 (50%)
	≤25%, >5	3 (37.5%)
	≤5%	0 (0%)
Endometrial adenocarcinoma, endometrial type (12 cases)	>75% to 100%	3 (25%)
	≤75%, >25%	4 (33.3%)
	≤25%, >5	4 (33.3%)
	≤5%	1 (8.3%)

^*Endometrial glands from endometrium without hyperplasia, neoplasia, or atrophy demonstrated 100% strong immunoreactivity in all samples.